StockData
BioStem Technologies, Inc. logo

BioStem Technologies, Inc. (BSEM) stock

BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)

Close on Nov 20, 2026Market cap $11.34MP/E –Yield –

BioStem Technologies cash

Cash and short-term investments held at the end of each period.

BioStem Technologies's cash was $6.96M at Jun 30, 2026. For fiscal 2025 it was $29.55M, up 29.4% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$29.55M+29.4%
FY2024Dec 31, 2024$22.83M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.96M–
Q4 FY2025Dec 31, 2025$29.55M–
Q2 FY2025Jun 30, 2025$30.84M–
Q4 FY2024Dec 31, 2024$22.83M–

More BioStem Technologies figures

See a number that looks wrong?